Pluristyx Revenue and Competitors
Estimated Revenue & Valuation
- Pluristyx's estimated annual revenue is currently $5.3M per year.
- Pluristyx's estimated revenue per employee is $155,000
Employee Data
- Pluristyx has 34 Employees.
- Pluristyx grew their employee count by 0% last year.
Pluristyx's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Operating Officer, Principal Consultant, and Co-Founder | Reveal Email/Phone |
2 | Co-Founder and CEO | Reveal Email/Phone |
3 | Chief Technology Officer | Reveal Email/Phone |
4 | Head Strategy & Corporate Development | Reveal Email/Phone |
5 | Director, Head Analytical Development and QC | Reveal Email/Phone |
6 | Research Associate | Reveal Email/Phone |
7 | Scientist | Reveal Email/Phone |
8 | Scientist | Reveal Email/Phone |
9 | General Counsel | Reveal Email/Phone |
10 | Research Engineer III | Reveal Email/Phone |
Pluristyx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Pluristyx?
Pluristyx, Inc. is an advanced therapy tools and service company serving customers in the rapidly growing field of regenerative medicine and cellular therapies. Pluristyx has a line of pluripotent stem cell based products and also offers contract development, manufacturing, and consulting services.
keywords:N/AN/A
Total Funding
34
Number of Employees
$5.3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 34 | 17% | N/A |
#2 | $7M | 34 | -6% | N/A |
#3 | $6000M | 34 | N/A | N/A |
#4 | $4.4M | 34 | -11% | N/A |
#5 | $3.9M | 34 | 10% | N/A |